Talphera (TLPH) Receivables (2015 - 2022)
Talphera (TLPH) posted Receivables of $309000.0 for Q4 2022, down 39.65% on a QoQ basis from $512000.0 in Q3 2022, and up 93.12% year-over-year from $160000.0 in Q4 2021.
Analysis
Talphera (TLPH) Receivables (2015 - 2022) Analysis & Trends
Talphera has reported Receivables for 8 years, with the latest figure at $309000.0 in Q4 2022.
- On a quarterly basis, Receivables rose 93.12% year-over-year to $309000.0 in Q4 2022; TTM through Dec 2022 was $309000.0, a 93.12% increase from a year earlier, with the FY2022 full-year figure at $309000.0, up 93.12% from the prior year.
- Receivables was $309000.0 for Q4 2022 at Talphera, down from $512000.0 in the prior quarter.
- The five-year high for Receivables was $1.1 million in Q3 2020, with the low at $49000.0 in Q4 2018.
- Average Receivables over 5 years is $393400.0, with a median of $276500.0 recorded in 2019.
- The sharpest annual moves came in 2018 and 2019: Receivables slumped 96.8% in 2018, then jumped 781.63% in 2019.
- Over 5 years, Receivables stood at $49000.0 in 2018, then jumped by 781.63% to $432000.0 in 2019, then jumped by 46.99% to $635000.0 in 2020, then sank by 74.8% to $160000.0 in 2021, then jumped by 93.12% to $309000.0 in 2022.
- The last three Receivables figures came in at $309000.0 (Q4 2022), $512000.0 (Q3 2022), and $364000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | 512,000.00 |
| Jun 30, 2022 | 364,000.00 |
| Mar 31, 2022 | 184,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 104,000.00 |
| Mar 31, 2021 | 658,000.00 |
| Dec 31, 2020 | 635,000.00 |
| Sep 30, 2020 | 1.13 Mn |
| Jun 30, 2020 | 195,000.00 |
| Mar 31, 2020 | 567,000.00 |
| Dec 31, 2019 | 432,000.00 |
| Sep 30, 2019 | 244,000.00 |
| Jun 30, 2019 | 221,000.00 |
| Mar 31, 2019 | 221,000.00 |
| Dec 31, 2018 | 49,000.00 |
| Sep 30, 2018 | 187,000.00 |
| Jun 30, 2018 | 773,000.00 |
| Mar 31, 2018 | 772,000.00 |